Monsanto ordered to pay $81 mn in Roundup cancer trial By Julie CHARPENTRAT San Francisco (AFP) March 28, 2019 Monsanto was ordered on Wednesday to pay some $81 million to an American retiree who blames his cancer on the agribusiness giant's weedkiller Roundup. A San Francisco jury found the firm, which is owned by Bayer, had been "negligent by not using reasonable care" to warn of the risks of its product, ordering it to pay Edwin Hardeman $75 million in punitive damages, $5.6 million in compensation and $200,000 for medical expenses. The jury also found that Roundup's design was defective and that the product lacked sufficient warnings of potential risk. The same jury had previously found that a quarter century exposure to Roundup, whose principal ingredient is controversial chemical glyphosate, was a "substantial factor" in giving the 70-year-old Hardeman non-Hodgkin's lymphoma. The verdict marks a major setback for Bayer, which purchased Monsanto last year for $63 billion and has seen its shares plunge because of the litigation. The company said it would appeal the verdict even though it sympathized with Hardeman's plight. "We are disappointed with the jury's decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic," Bayer said in a statement. "The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances." Hardeman's attorneys, who cheered and hugged their client as the verdict was announced, said they were pleased the jury had unanimously ruled in his favor and that Monsanto was being held accountable. "It is clear from Monsanto's actions that it does not care whether Roundup causes cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about Roundup," attorneys Aimee Wagstaff and Jennifer Moore said in a statement. "It speaks volumes that not one Monsanto employee, past or present, came live to trial to defend Roundup's safety or Monsanto's actions." - 'Back against the wall' - The case is one of more than 11,200 similar cases in the US alone involving Roundup. Last year, Monsanto lost a case to a California school groundskeeper suffering from terminal non-Hodgkin's lymphoma, who had sued the company over the glyphosate weedkillers Roundup and Ranger Pro. Monsanto was initially ordered to pay $289 million to Dewayne Johnson, before the damages were reduced to $78.5 million Bayer has also filed an appeal in that case. Monsanto has consistently denied that the weedkiller causes cancer and challenged findings by the International Agency for Research on Cancer, an agency of the World Health Organization (WHO), which classified glyphosate as a "probable carcinogen" in 2015. But other major agencies like the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA) or the US Environmental Protection Agency (EPA) have not followed suit. Carl Tobias, a law professor at the University of Richmond, told AFP that Hardeman's case was "important as a bellwether, which means it helps predict how future cases will be decide." Tobias said the verdict "bodes well" for plaintiffs in the thousands of other cases filed against Monsanto, and was "likely to encourage plaintiffs and their counsel to be more vigorous in pursuing their cases and will lead more potential plaintiffs to file suit." The Environmental Working Group, a non-profit, cheered Wednesday's verdict. "Clearly, the testimony that informed the jury's decision was Bayer-Monsanto hiding Roundup's carcinogenic properties, manipulating the science and cozying-up with EPA so it would not have to warn consumers of its dangerous product," said the group's president Ken Cook. "Bayer-Monsanto has known for decades the cancer-causing properties of Roundup and I applaud the jury for holding the company accountable for failing to warn consumers of the known danger." "This verdict puts Bayer's back firmly up against the wall as the cost of litigation mounts and its stock price gets pummeled once again," he added.
Seeds share memories with their offspring Washington (UPI) Mar 26, 2019 Seeds inherit memories from their mom. According to a new study, the experiences of a mother seed influence the dormant states of offspring. When environmental conditions aren't ideal, seeds temporarily block germination and remain in a dormant state. Groups of "interfering" RNA, which carry the imprinted memories, put a hold on the germination process by blocking key genes. In addition to delivering memories of the mother's dormant state to the next generation of seeds, the interfering ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |